Zydus Jarod Plant Gets USFDA VAI Classification
x
Zydus Lifesciences receives VAI classification from USFDA for its Jarod injectable manufacturing plant after inspection. Details inside.
Photograph: Courtesy Zydus.
New Delhi, Dec 4 (PTI) Zydus Lifesciences on Thursday said it has received Establishment Inspection Report from the US health regulator for its Jarod-based injectable manufacturing facility.
The US Food and Drug Administration (USFDA) inspected the plant at Jarod, Vadodara from August 25 to September 5, 2025.
The health regulator has classified the facility as Voluntary Action Indicated (VAI) indicating that minor issues were found during an inspection.
This inspection at the plant was conducted following the Warning Letter issued on August 29, 2024 by the USFDA.
Zydus Lifesciences shares on Thursday ended flat at Rs 935.40 apiece on BSE.
The US Food and Drug Administration (USFDA) inspected the plant at Jarod, Vadodara from August 25 to September 5, 2025.
The health regulator has classified the facility as Voluntary Action Indicated (VAI) indicating that minor issues were found during an inspection.
This inspection at the plant was conducted following the Warning Letter issued on August 29, 2024 by the USFDA.
Zydus Lifesciences shares on Thursday ended flat at Rs 935.40 apiece on BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Alstone-Textiles
- 0.17 ( 0.00)
- 73180863
- Mangalam-Industrial
- 1.11 (+ 4.72)
- 36071038
- Kretto-Syscon
- 0.67 (+ 19.64)
- 24353397
- Vodafone-Idea
- 11.36 ( -1.65)
- 23318720
- Spicejet
- 18.04 ( -11.61)
- 19287146
MORE NEWS
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback